IRUS Total

Are disruptive innovations recognised in the healthcare literature? A systematic review

File Description SizeFormat 
208.full.pdfPublished version844.87 kBAdobe PDFView/Open
Title: Are disruptive innovations recognised in the healthcare literature? A systematic review
Authors: Sounderajah, V
Patel, V
Varatharajan, L
Harling, L
Normahani, P
Symons, J
Barlow, J
Darzi, A
Ashrafian, H
Item Type: Journal Article
Abstract: The study aims to conduct a systematic review to characterise the spread and use of the concept of ‘disruptive innovation’ within the healthcare sector. We aim to categorise references to the concept over time, across geographical regions and across prespecified healthcare domains. From this, we further aim to critique and challenge the sector-specific use of the concept. PubMed, Medline, Embase, Global Health, PsycINFO, Maternity and Infant Care, and Health Management Information Consortium were searched from inception to August 2019 for references pertaining to disruptive innovations within the healthcare industry. The heterogeneity of the articles precluded a meta-analysis, and neither quality scoring of articles nor risk of bias analyses were required. 245 articles that detailed perceived disruptive innovations within the health sector were identified. The disruptive innovations were categorised into seven domains: basic science (19.2%), device (12.2%), diagnostics (4.9%), digital health (21.6%), education (5.3%), processes (17.6%) and technique (19.2%). The term has been used with increasing frequency annually and is predominantly cited in North American (78.4%) and European (15.2%) articles. The five most cited disruptive innovations in healthcare are ‘omics’ technologies, mobile health applications, telemedicine, health informatics and retail clinics. The concept ‘disruptive innovation’ has diffused into the healthcare industry. However, its use remains inconsistent and the recognition of disruption is obscured by other types of innovation. The current definition does not accommodate for prospective scouting of disruptive innovations, a likely hindrance to policy makers. Redefining disruptive innovation within the healthcare sector is therefore crucial for prospectively identifying cost-effective innovations.
Issue Date: 29-Dec-2020
Date of Acceptance: 25-Jul-2020
URI: http://hdl.handle.net/10044/1/83380
DOI: 10.1136/bmjinnov-2020-000424
ISSN: 2055-8074
Publisher: BMJ
Start Page: 208
End Page: 216
Journal / Book Title: BMJ Innovations
Volume: 7
Issue: 1
Copyright Statement: © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Sponsor/Funder: Imperial College Healthcare NHS Trust- BRC Funding
National Institute of Health Research
Funder's Grant Number: RDB04
Keywords: global health
reverse innovations
Publication Status: Published
Online Publication Date: 2020-09-04
Appears in Collections:Imperial College Business School
Department of Surgery and Cancer
Faculty of Medicine
Institute of Global Health Innovation
School of Public Health

This item is licensed under a Creative Commons License Creative Commons